Advantages and disadvantages of coronary drug-eluting stent: a 23-year journey of randomized clinical trials
Introducing drug-eluting stents (DES2) significantly reduced target vessel revascularization (TVR), TVR-myocardial infarction (MI), and definitive stent thrombosis. Cardiac death in high-risk subgroups of lesions was also significantly reduced, and all of this is out of the discussion for...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia.edu Journals
2024-07-01
|
| Series: | Academia Medicine |
| Online Access: | https://www.academia.edu/121774093/Advantages_and_disadvantages_of_coronary_drug_eluting_stent_a_23_year_journey_of_randomized_clinical_trials |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|